Bayer Investor Relations Material
Latest events
CMD 2024
Bayer
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Bayer AG
Access all reports
Segment Data
Access more data
Net sales by
Business area
Crop Science
Pharmaceuticals
Consumer Health
Enabling Functions and Consolidation
Other
Expenses by
Financials
Bayer AG operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The company researches, develops, manufactures, and markets prescription products primarily for the areas of cardiology and women's healthcare; and specialty therapeutics in the areas of oncology, hematology, and ophthalmology. It is also involved in developing over-the-counter medications and dietary supplements.
Key slides for Bayer AG
J.P. Morgan 42nd Annual Healthcare Conference 2024
Bayer AG
Q4 2023
Bayer AG
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇩🇪 Germany